Connection

Richard Silver to Lung Diseases

This is a "connection" page, showing publications Richard Silver has written about Lung Diseases.
Connection Strength

1.564
  1. Biomarkers of scleroderma lung disease: recent progress. Curr Rheumatol Rep. 2011 Feb; 13(1):44-50.
    View in: PubMed
    Score: 0.325
  2. Pulmonary manifestations of scleroderma and mixed connective tissue disease. Clin Chest Med. 2010 Sep; 31(3):433-49.
    View in: PubMed
    Score: 0.315
  3. Assessment of lung involvement. Clin Exp Rheumatol. 2003; 21(3 Suppl 29):S19-23.
    View in: PubMed
    Score: 0.185
  4. Scleroderma. Clinical problems. The lungs. Rheum Dis Clin North Am. 1996 Nov; 22(4):825-40.
    View in: PubMed
    Score: 0.121
  5. Systemic sclerosis (scleroderma). Clinical management of its major complications. Rheum Dis Clin North Am. 1995 Feb; 21(1):203-16.
    View in: PubMed
    Score: 0.107
  6. Lung disease in systemic sclerosis (scleroderma). Baillieres Clin Rheumatol. 1993 Feb; 7(1):79-97.
    View in: PubMed
    Score: 0.093
  7. High resolution computed tomography in early scleroderma lung disease. J Rheumatol. 1991 Oct; 18(10):1520-8.
    View in: PubMed
    Score: 0.085
  8. Lung involvement in systemic sclerosis. Rheum Dis Clin North Am. 1990 Feb; 16(1):199-216.
    View in: PubMed
    Score: 0.076
  9. Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease: results from the scleroderma lung study. Arthritis Rheum. 2007 May; 56(5):1676-84.
    View in: PubMed
    Score: 0.063
  10. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study. Arthritis Rheum. 2005 Feb; 52(2):592-600.
    View in: PubMed
    Score: 0.054
  11. Interstitial lung disease in scleroderma. Analysis by bronchoalveolar lavage. Arthritis Rheum. 1984 Nov; 27(11):1254-62.
    View in: PubMed
    Score: 0.053
  12. Update of EULAR recommendations for the treatment of systemic sclerosis. Ann Rheum Dis. 2017 Aug; 76(8):1327-1339.
    View in: PubMed
    Score: 0.030
  13. Pathophysiology of the eosinophilia-myalgia syndrome. J Rheumatol Suppl. 1996 Oct; 46:26-36.
    View in: PubMed
    Score: 0.030
  14. Clinical aspects of systemic sclerosis (scleroderma). Ann Rheum Dis. 1991 Nov; 50 Suppl 4:854-61.
    View in: PubMed
    Score: 0.021
  15. The eosinophilia-myalgia syndrome--guidelines for patient care. J Rheumatol. 1995 Jan; 22(1):161-3.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.